Evolution of the Average Target: Tenet Healthcare Corporation

Evolution of the Target Price: Tenet Healthcare Corporation

Changes in Analyst Recommendations: Tenet Healthcare Corporation

d584c034c7.Cbj1FvbaAqVmDINMZ40EJVDXeVruM7bl62RSshZ2q50.UMDHcpK0eJMqRNQmMKA9EBbjGA-YWdDXnhwagmMA2d9qgIJjgeNHlyg1zg~2eb0dce17caa76856fcdf2ae446ccff2
02-12 UBS Adjusts Price Target on Tenet Healthcare to $288 From $260, Maintains Buy Rating MT
02-12 Deutsche Bank Raises Price Target on Tenet Healthcare to $260 From $235, Keeps Buy Rating MT
02-12 RBC Raises Price Target on Tenet Healthcare to $277 From $253, Keeps Outperform Rating MT
02-12 Morgan Stanley Raises Price Target on Tenet Healthcare to $260 From $247, Keeps Overweight Rating MT
02-12 Analyst recommendations: Pfizer, Applovin, Biogen, Hilton, Snap… Zonebourse
02-03 Tenet Reports 'Solid' Preliminary Results, RBC Says MT
02-03 RBC Lifts Price Target on Tenet Healthcare to $253 From $252, Keeps Outperform Rating MT
01-06 Hospitals Face Headwinds in 2026 Amid Moderating Fundamentals, Restrictive Policy, BofA Says MT
01-06 BofA Securities Lifts Price Target on Tenet Healthcare to $240 From $230, Maintains Buy Rating MT
11-03 RBC Raises Price Target on Tenet Healthcare to $252 From $230, Keeps Outperform Rating MT
11-03 Truist Raises Price Target on Tenet Healthcare to $240 From $225, Keeps Buy Rating MT
29/10/25 Deutsche Bank Adjusts Tenet Healthcare Price Target to $235 From $200, Maintains Buy Rating MT
29/10/25 UBS Adjusts Price Target on Tenet Healthcare to $260 From $238, Maintains Buy Rating MT
29/10/25 Morgan Stanley Raises Price Target on Tenet Healthcare to $232 From $225, Keeps Overweight Rating MT
08/09/25 RBC Capital Adjusts Price Target on Tenet Healthcare to $230 From $189, Maintains Outperform Rating MT
28/07/25 Wolfe Downgrades Tenet Healthcare to Peer Perform From Outperform MT
16/07/25 Truist Raises Price Target on Tenet Healthcare to $205 From $190, Keeps Buy Rating MT
29/05/25 Tenet Healthcare Shares Rise After Wells Fargo Upgrade MT
29/05/25 Wells Fargo Upgrades Tenet Healthcare to Overweight From Equalweight, Adjusts Price Target to $195 From $150 MT
21/05/25 Analyst recommendations: The Home Depot, UnitedHealth, Dell, Tenet Healthcare… Zonebourse
12/05/25 Analyst recommendations: Hilton, Micron, Target, Lyft, Carvana… Zonebourse
05/05/25 Tenet Healthcare Poised to Benefit from Outpatient Growth due to ASC Leadership, Morgan Stanley Says MT
05/05/25 Morgan Stanley Raises Price Target on Tenet Healthcare to $175 From $165, Keeps Overweight Rating MT
30/04/25 Tenet Healthcare Q1 Results Exceed Expectations Due to Strong Volume, Cost Control, RBC Says MT
30/04/25 UBS Adjusts Price Target on Tenet Healthcare to $230 From $217, Maintains Buy Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+10.32%
-1.84%
+20.85%
+9.92%
+12.32%
+6.21%
+4.62%
+18.59%
+6.62%
+10.19%
Average +9.78%
Weighted average by Cap. +9.00%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
231.10USD
Average target price
254.95USD
Spread / Average Target
+10.32%
High Price Target
288.00USD
Spread / Highest target
+24.62%
Low Price Target
213.00USD
Spread / Lowest Target
-7.83%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

UBS
Deutsche Bank Securities
RBC Capital Markets
Morgan Stanley
BofA Securities
Truist Securities
Wolfe Research
Wells Fargo Securities
Baird
Guggenheim
TD Cowen
KeyBanc Capital Markets
Goldman Sachs
Raymond James
Mizuho Securities
Cantor Fitzgerald
JPMorgan Chase
Credit Suisse
Stephens Inc.
Citigroup
Barclays
Jefferies & Co.
Loop Capital
SVB Securities LLC
Stifel Nicolaus
SVB Leerink
Seaport Global Securities
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
231.10USD
Average target price
254.95USD
Spread / Average Target
+10.32%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. THC Stock
  4. Consensus Tenet Healthcare Corporation